Microbix Hosts Ontario Premier, Showcases Innovations in Life Sciences

Microbix Biosystms ( (TSE:MBX) ) just unveiled an update.

Microbix Biosystems Inc. recently hosted Ontario Premier Doug Ford and MPP Deepak Anand at their Mississauga facilities, highlighting their role as a leading Ontario-based life sciences company. The visit underscored the company’s contributions to healthcare through innovative diagnostic tests that improve patient outcomes and reduce costs. Microbix has benefited from over C$ 2.0 million in grant funding from Ontario’s government, which has supported the development of world-leading healthcare products and reinforced the company’s commitment to maintaining its operations in Ontario.

More about Microbix Biosystms

Microbix Biosystems Inc. is a life sciences company that creates proprietary biological products for human health. It employs over 120 skilled workers and generates sales targeting C$ 2.0 million or more per month. The company manufactures and exports critical ingredients and devices for the global diagnostics industry, including antigens for immunoassays and laboratory quality assessment products (QAPs™). Microbix’s products are available in over 30 countries and the company is ISO 9001 & 13485 accredited, U.S. FDA registered, Australian TGA registered, and Health Canada establishment licensed.

YTD Price Performance: 15.00%

Average Trading Volume: 169,105

Technical Sentiment Consensus Rating: Strong Sell

Current Market Cap: C$61.86M

For a thorough assessment of MBX stock, go to TipRanks’ Stock Analysis page.